Table 3.
Type | Treatment | Target/Experimental Model | Mechanism | Outcome | Ref |
---|---|---|---|---|---|
In vitro | MSC-CM | HSCs | Reducing expressions of pro-fibrotic genes |
Inhibition of HSCs activation |
[131] |
Cytokine, TSG-6 | HSCs | Decreasing HSC activation Promoting the transdifferentiation of activated HSCs into stem-like cells |
Amelioration of liver fibrosis |
[136] | |
MSC-exosomes | HSCs | Inhibiting Wnt/β-catenin signaling | Inhibition of HSC activation |
[144] | |
Co-culture with miR-125b manipulated MSCs |
LX2 | Targeting Smo; suppression of Hh signaling |
Inhibition of HSC activation |
[149] | |
In vivo | MSC-CM | CCl4-induced liver fibrosis in mice | Reducing collagen accumulation and inflammation Elevating hepatocyte survival |
Amelioration of liver fibrosis |
[132] |
Cytokine, TSG-6 | CCl4-induced liver fibrosis in mice | Inducing M2 polarization Upregulating MMP12 expression in macrophages |
Amelioration of liver fibrosis |
[137] | |
Cytokine, MFGE 8 | TAA or CCl4-induced liver fibrosis in mice | Downregulating the expression of TGFβR1 of HSC | Amelioration of liver fibrosis |
[138] | |
MSC-exosomes | CCl4-induced liver fibrosis in mice | Reducing hepatocyte death Decreasing oxidative stress |
Amelioration of liver fibrosis |
[142] | |
CCl4-induced liver fibrosis in mice | Inactivating TGF-β/SMAD signaling pathway |
Amelioration of liver fibrosis |
[143] | ||
CCl4-induced liver fibrosis in rats | Suppressing Wnt/β-catenin signaling |
Improvement of liver function |
[144] | ||
GPX1 delivered by the MSC-exosomes | CCl4-induced liver fibrosis in mice | Decreasing oxidative stress Increasing hepatocyte proliferation |
Amelioration of liver fibrosis |
[145] | |
miR-150-5p contained in MSC-exosomes | CCl4-induced liver fibrosis in mice | Reducing the expression of CXCL-1 |
Amelioration of liver fibrosis |
[14] | |
miR-1246 contained in MSC-exosomes | ischemia/reperfusion-induced liver injury in mice | Modulating the balance of regulatory T cells and Th17 cells |
Protection of hepatocytes Suppression of inflammation | [147] | |
miR-486-5p contained in MSC-exosomes | CCl4-induced liver fibrosis in mice | Suppressing Hh signaling | Amelioration of liver fibrosis |
[148,149] | |
miR-125b contained in MSC-exosomes | CCl4-induced liver fibrosis in rats |
MSC, Mesenchymal stem cell; HSC, Hepatic stellate cell; CM, Conditioned media; TSG-6, Tumor necrosis factor-inducible gene 6 protein; miR, MicroRNA; Hh, Hedgehog; Smo, Smoothened; MMP12, Matrix metalloproteinase 12; MFGE8, Milk fat globule EGF factor 8 protein; CCl4, Carbon tetrachloride; TAA, Thioacetamide; TGFβR1, Transforming growth factor beta-receptor 1; TGF-β, Transforming growth factor beta; GPX1, Glutathione peroxidase 1; Th17, T helper 17; CXCL-1, CXC chemokine-ligand-1.